MetaCell s.r.o., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cells, disseminated tumor cells and circulating endometrial cells.

The offered tests provide information to oncologists and gynecologists enabling them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumor or endometrial cells detected in circulation or bodily fluids.

MetaCell s.r.o., is a cancer research company providing contract drug discovery and evaluation service to pharmaceutical and biotechnology companies. The company sells its products and services through own sales force and partners focusing on selling directly to diagnostic and research community worldwide.